Connected pillbox maker MedMinder received $35 million through a credit facility with SWK Holdings Corporation and additional investment from Accelmed Partners.

The company offers a connected medication dispenser with an interactive screen that alerts polypharmacy patients, seniors and caregivers when it’s time to take medications or when a dose is missed. It also provides a service where patients are delivered pre-filled and organized prescription trays to add to their pillbox. 

MedMinder most recently announced a $40 million raise in March 2021. 

“We are honored to establish a relationship with SWK and expand our relationship with Accelmed. Both partners are industry leaders who will be instrumental in helping us achieve our mission,” CEO Mike Edwards said in a statement. “The demand for our services from patients and payers has never been greater. This additional investment will allow MedMinder to more deeply impact the lives of polypharmacy and senior patients nationally.”


Psych Hub, which offers mental health educational resources for practitioners and consumers, raised $16 million in a funding round co-led by HC9 and Frist Cressey Ventures. 

Other participants in the raise include HealthStream, Emerson Collective and Bailey & Co.’s strategic fund.

Psych Hub plans to use the funds to launch a new product, Psych Hub Connect, that will match users with in-network mental health professionals based on expertise and cultural fit. 


Power, which offers a search tool for patients to find and enroll in clinical trials, emerged from stealth Tuesday with $7 million in seed funding.

The round was led by Footwork and CRV, with participation from ARTIS Ventures, South Park Commons and AirAngels.

“Historically, clinical trials have relied on recruiting patients who are being treated at large, prestigious medical institutions and/or have active, hands-on support from a physician or patient advocate. Most other patients rely on the kindness of strangers on the internet,” cofounder Brandon Li said in a statement.

“One of our top priorities when we started Power was to create easy access to clinical trials for all patients who need to explore innovative treatments. It should not be as hard as it is today.”


Real-world data startup CuriMeta announced it had raised $6 million in a seed funding round led by BJC HealthCare and Washington University School of Medicine in St. Louis.

Additionally, CuriMeta will partner with BJC and WashU Medicine to build a platform to share real-world datasets with life science companies, selecting projects and collaborators that align with the providers’ research interests. 

“We are investing significantly in augmenting and improving the usefulness of the data, not just gathering it,” Davis Walp, CuriMeta founder and CEO, said in a statement. “Our data experts will curate, harmonize and apply machine learning techniques to enhance the quality, completeness and research value of our collaborators’ data. This is a team of mission focused industry veterans who understand the pressing scientific and clinical challenges that researchers are solving for. We’re aggregating and delivering advanced, real-world health data designed to answer those questions and address those needs.”

Cultivation Capital Healthcare Innovation Fund is also an investor in the startup.


Healee, which offers customizable telehealth and appointment scheduling tools to healthcare organizations, raised $2M in a seed round led by Nina Capital.

Other participants include Calm/Storm Ventures, KAYA VC and existing investor Eleven Ventures. The startup plans to use the capital to develop its technology and expand in the U.S. 

“Healee offers you an advanced, yet easy way to get started with digital health while building your brand and adapting your tool for better user engagement,” CEO and founder Hristo Kosev said in a statement.

[ad_2]
Post source: Mobi Health